Enhancing Tumor Segmentation on BraTS ET 2023 benchmark leaderboard · SOTA2 Research

Enhancing Tumor Segmentation on BraTS ET 2023

51.46DSC (FLAIR)IM-Fuse+MGML

Evaluation Results

Method	Links
IM-Fuse+MGML2025.12		51.46	82.59	45.02	57.53	83.18	84.39	59.53	85.46	56.83	82.41	53.36	85.54	85.73	55.27	86.21	70.3
RFNet+MGML2025.12		50.12	81.05	43.89	56.05	81.64	82.76	58.21	83.99	55.32	81.05	51.97	83.99	84.01	53.78	84.61	68.83
IM-Fuse2025.12		49.67	81.65	44.26	56.93	82.66	83.81	58.83	84.64	55.88	81.45	52.39	84.57	84.91	54.12	85.41	69.41
mmFormer+MGML2025.12		49.08	80.7	43.32	55.42	81.18	82.21	57.64	83.5	54.91	80.52	51.48	83.41	83.55	53.21	84.16	68.29
RFNet2025.12		48.05	79.9	42.87	54.81	80.52	81.61	57.08	82.92	54.17	79.85	50.78	82.85	82.97	52.72	83.48	67.64
mmFormer2025.12		45.1	77.18	41.1	53.05	79.15	80.21	55.93	81.54	53.08	78.2	49.12	81.12	81.84	51.61	82.09	66.02
U-HVED2025.12		39.46	72.45	31.67	45.12	71.86	73.12	50.04	76.14	48.64	72.45	42.16	75.35	74.82	73.69	74.24	61.41